Gene · 2358
Papers3,281
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,281
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Annexins and autoantibodies in autoimmune diseases - Insights into SLE, APS and RA: A review. | Biomol Biomed | 2026 | 41542857 | PubTator, text mining | PubMed |
| Mitochondrial-derived microproteins in cancer and neurodegeneration: A new era of cross-disease mechanistic insights. | Pathol Res Pract | 2026 | 41468641 | PubTator, text mining | PubMed |
| LAT1/SLC7A5-mediated amino acid uptake is regulated by redox signals triggered by formyl-peptide receptor 2. | FEBS J | 2026 | 41422484 | PubTator, text mining | PubMed |
| Cross-Platform Biosensing of Immune Receptors Using Peptide-Functionalized Graphene. | Adv Sci (Weinh) | 2026 | 41387356 | PubTator, text mining | PubMed |
| Investigation into ligand selectivity and bias at the formyl peptide receptor family. | J Pharmacol Exp Ther | 2026 | 41371001 | PubTator, text mining | PubMed |
| Identification of a formyl peptide receptor 1 inhibitor through structure-based virtual screening. | Biochem Pharmacol | 2026 | 41349908 | PubTator, text mining | PubMed |
| Formylpeptide receptors: A novel target to treat cardiometabolic complications. | Pharmacol Ther | 2026 | 41151623 | PubTator, text mining | PubMed |
| ALX/FPR2 - the spleen's cellular cleanup crew! | Haematologica | 2026 | 41098097 | PubTator, text mining | PubMed |
| Biological Effects of Calceolarioside A as a Natural Compound: Anti-Ovarian Cancer, Anti-Tyrosinase, and Anti-HMG-CoA Reductase Potentials with Molecular Docking and Dynamics Simulation Studies. | Mol Biotechnol | 2026 | 39820851 | PubTator, text mining | PubMed |
| Targeted lipidomics meets transcriptomics: how cinobufagin rewires fatty acid, sphingolipid, and glycerophospholipid metabolism to combat hepatoma cell growth. | Front Pharmacol | 2025 | 41737012 | PubTator, text mining | PubMed |
| Increased cathelicidin LL-37 colonic expression is associated with tumor progression in colorectal cancer. | J Physiol Pharmacol | 2025 | 41569060 | PubTator, text mining | PubMed |
| Annexin A1 and A2 in inflammatory bowel disease pathogenesis: exploring new avenues for diagnosis and treatment. | Front Immunol | 2025 | 41550928 | PubTator, text mining | PubMed |
[Chemical constituents, biological activity evaluation of Rhododendron tomentosum, and mechanisms of its anti-inflammatory, antioxidant, and anti-rheumatoid arthritis activities based on network pharmacology and molecular docking technology]. | Zhongguo Zhong Yao Za Zhi | 2025 | 41507718 | PubTator, text mining | PubMed |
| Integrating machine learning and molecular docking to elucidate the mechanism of atrial fibrillation induced by di(2-ethylhexyl) phthalate. | Sci Rep | 2025 | 41469761 | PubTator, text mining | PubMed |
| Resolvin D1 Modulates the Inflammatory Processes of Human Periodontal Ligament Cells via NF-κB and MAPK Signaling Pathways. | Biomedicines | 2025 | 41463049 | PubTator, text mining | PubMed |
| Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure. | Eur Heart J Open | 2025 | 41451243 | PubTator, text mining | PubMed |
| MSC administration resolves experimental acute gout increasing specialized pro-resolving mediators synthesis through a super-induction of prostaglandin E2. | Stem Cell Res Ther | 2025 | 41449409 | PubTator, text mining | PubMed |
| CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein-Coupled Receptors. | Eur J Immunol | 2025 | 41420480 | PubTator, text mining | PubMed |
| Comprehensive analysis of the role of diverse programmed cell death patterns in sepsis. | Front Immunol | 2025 | 41346577 | PubTator, text mining | PubMed |
| Protein-Protein Interactions in Papillary and Nonpapillary Urothelial Carcinoma Architectures: Comparative Study. | JMIR Bioinform Biotechnol | 2025 | 41342186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2358/papers?page=4